These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25133561)

  • 1. [Treatment of primary open angle glaucoma in a case of multiple chemical sensitivity syndrome: a case report].
    Attia M; Fitting A; Auffarth GU; Kretz FT
    Klin Monbl Augenheilkd; 2014 Aug; 231(8):835-6. PubMed ID: 25133561
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistency with glaucoma medication.
    Fiscella RG
    Am J Ophthalmol; 2004 Dec; 138(6):1093-4; author reply 1094. PubMed ID: 15629333
    [No Abstract]   [Full Text] [Related]  

  • 3. The medical management of primary open-angle glaucoma in the elderly patient.
    Schoevaerdts D; Levecq L; Vanpee D; Swine C
    Z Gerontol Geriatr; 2003 Apr; 36(2):121-3. PubMed ID: 12720024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glaucoma--strategy of treatment].
    Stefan C; Selaru D; Stefaniu I; Dumitrică DM
    Oftalmologia; 2008; 52(3):3-6. PubMed ID: 19149110
    [No Abstract]   [Full Text] [Related]  

  • 5. Alphagan allergy may increase the propensity for multiple eye-drop allergy.
    Osborne SA; Montgomery DM; Morris D; McKay IC
    Eye (Lond); 2005 Feb; 19(2):129-37. PubMed ID: 15254495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lowering of intraocular pressure with clonidin].
    Edelhauser E; Nemetz U
    Klin Monbl Augenheilkd; 1972 Feb; 160(2):188-93. PubMed ID: 5018069
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistency and tolerability of ocular hypotensive agents: population-based evidence in the management of glaucoma.
    Schwartz GF
    Am J Ophthalmol; 2004 Jan; 137(1 Suppl):S1-2. PubMed ID: 14697908
    [No Abstract]   [Full Text] [Related]  

  • 8. Modern alchemy: fixed combinations of glaucoma drugs.
    Katz LJ
    Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653
    [No Abstract]   [Full Text] [Related]  

  • 9. [General substance classification and pharmacology of glaucoma].
    Thieme H; Renieri G; Schuart C
    Ophthalmologe; 2013 Dec; 110(12):1149-54. PubMed ID: 24337206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pleiotropic effects in local drug treatment for glaucoma].
    Erb C
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):141-5. PubMed ID: 23430678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Compliance in glaucoma].
    Stefan C; Dumitrică DM
    Oftalmologia; 2008; 52(3):7-9. PubMed ID: 19149111
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glaucoma and dry eye. Current concepts and future perspectives].
    Steven P; Cursiefen C
    Ophthalmologe; 2013 Dec; 110(12):1155-9. PubMed ID: 24129917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sensitivity to theophylline associated with primary open-angle glaucoma.
    Zink HA; Palmberg PF; Bigger JF
    Invest Ophthalmol; 1973 Aug; 12(8):603-7. PubMed ID: 4355045
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypotony and choroidal effusion induced by topical timolol and dorzolamide in patients with previous glaucoma drainage device implantation.
    Callahan C; Ayyala RS
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):467-9. PubMed ID: 14620750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma.
    Shah R; Wormald R
    Clin Evid; 2002 Jun; (7):589-96. PubMed ID: 12230685
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bimatoprost versus timolol and dorzolamide.
    Tressler CS
    Ophthalmology; 2005 Feb; 112(2):357-8; author reply 358-9. PubMed ID: 15691575
    [No Abstract]   [Full Text] [Related]  

  • 18. Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
    Becker HI; Walton RC; Diamant JI; Zegans ME
    Arch Ophthalmol; 2004 Jul; 122(7):1063-6. PubMed ID: 15249377
    [No Abstract]   [Full Text] [Related]  

  • 19. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24-Hour intraocular pressure control between travoprost/timolol fixed combination, latanoprost/ timolol fixed combination and standard timolol in primary open angle glaucoma and ocular hypertension.
    Pachimkul P; Yuttitham K; Thoophom P
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S81-7. PubMed ID: 21717884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.